Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Sher

Showing results (111-120 of 159) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2023
Efficacy and Quality-of-Life Following Involved Nodal Radiotherapy for Head and Neck Squamous Cell Carcinoma: The INRT-AIR Phase II Clinical TrialDavid J Sher, Dominic H Moon, Dat Vo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2019
Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic AdenocarcinomaNina N Sanford, Todd A Aguilera, Michael R Folkert, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2015
Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal ResponseEllis Ziel, Gregory Hermann, Neilayan Sen, et al.
Oral Oncology|November 22, 2020
Survivin expression and impact on head and neck cancer outcomesSaad A Khan, Michael Burke, Fang Zhu, et al.
Journal of Neuro-Oncology|January 31, 2008
The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastomaDavid J Sher, John W Henson, Bindu Avutu, et al.
Cancer|May 18, 2017
Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysisPriscilla K Stumpf, Arya Amini, Bernard L Jones, et al.
Cancer|October 6, 2017
Reply to Tumor localization may change the type of adjuvant treatment in gastric cancerPriscilla K Stumpf, Arya Amini, Bernard L Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2025
Dosimetric Advantages of Online Adaptive Radiation Therapy for Head and Neck Squamous Cell Carcinoma: Results From a Prospective Registry StudyJulia J Shi, Krithi Meduri, Chien-Yi Liao, et al.
Journal of Oncology Practice|March 21, 2018
Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non-Small-Cell Lung CancerSteven K M Lau, Bhavani S Gannavarapu, Kristen Carter, et al.
International Journal of Radiation Oncology, Biology, Physics|December 24, 2010
Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neckDavid J Sher, Tracy A Balboni, Robert I Haddad, et al.
Pageof 16

Showing results (111-120 of 159) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2023
Efficacy and Quality-of-Life Following Involved Nodal Radiotherapy for Head and Neck Squamous Cell Carcinoma: The INRT-AIR Phase II Clinical TrialDavid J Sher, Dominic H Moon, Dat Vo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2019
Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic AdenocarcinomaNina N Sanford, Todd A Aguilera, Michael R Folkert, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2015
Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal ResponseEllis Ziel, Gregory Hermann, Neilayan Sen, et al.
Oral Oncology|November 22, 2020
Survivin expression and impact on head and neck cancer outcomesSaad A Khan, Michael Burke, Fang Zhu, et al.
Journal of Neuro-Oncology|January 31, 2008
The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastomaDavid J Sher, John W Henson, Bindu Avutu, et al.
Cancer|May 18, 2017
Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysisPriscilla K Stumpf, Arya Amini, Bernard L Jones, et al.
Cancer|October 6, 2017
Reply to Tumor localization may change the type of adjuvant treatment in gastric cancerPriscilla K Stumpf, Arya Amini, Bernard L Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2025
Dosimetric Advantages of Online Adaptive Radiation Therapy for Head and Neck Squamous Cell Carcinoma: Results From a Prospective Registry StudyJulia J Shi, Krithi Meduri, Chien-Yi Liao, et al.
Journal of Oncology Practice|March 21, 2018
Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non-Small-Cell Lung CancerSteven K M Lau, Bhavani S Gannavarapu, Kristen Carter, et al.
International Journal of Radiation Oncology, Biology, Physics|December 24, 2010
Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neckDavid J Sher, Tracy A Balboni, Robert I Haddad, et al.
Pageof 16